Complete pathological response to crizotinib in a patient with ALK-rearranged lung adenocarcinoma Journal Article

   

Authors:	Mattar, M. S.; Chang, J.; Benayed, R.; Halpenny, D.; Powers, A.; Kleiner, D. E.; Drilon, A.; Kris, M. G.
Article Title:	Complete pathological response to crizotinib in a patient with ALK-rearranged lung adenocarcinoma
Keywords:	clinical article; aged; case report; mass spectrometry; computer assisted tomography; coughing; dyspnea; thorax pain; lung adenocarcinoma; fluorescence in situ hybridization; bronchoscopy; pleura effusion; heart arrhythmia; autopsy; tyrosine kinase inhibitor; lethargy; mediastinoscopy; thoracoscopy; pleura metastasis; lung hemorrhage; anaplastic lymphoma kinase; eml4-alk; crizotinib; human; male; article; non–small-cell lung cancer; eml4-alk variants; tandem atypical propeller eml domain
Journal Title:	Clinical Lung Cancer
Volume:	21
Issue:	1
ISSN:	1525-7304
Publisher:	Elsevier Inc.
Date Published:	2020-01-01
Start Page:	e25
End Page:	e29
Language:	English
DOI:	10.1016/j.cllc.2019.10.002
PUBMED:	31690489
PROVIDER:	scopus
PMCID:	PMC6996866
DOI/URL:	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85074405432&doi=10.1016%2fj.cllc.2019.10.002&partnerID=40&md5=fc56d0c59a9a19d778031d9c5d142078
Notes:	Article -- Export Date: 3 February 2020 -- Source: Scopus

https://synapse.mskcc.org/synapse/works/has_related_data_chk/159963